Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 6075 entries
Sorted by: Best Match Show Resources per page
Tangzhining exhibits a protective effect against cognitive dysfunction in diabetic rats.

International journal of clinical and experimental medicine

Song X, Wang W, Kang Y, Zhang X, Jiang Y, Yue Z, Tang Z.
PMID: 26309554
Int J Clin Exp Med. 2015 Jun 15;8(6):9013-21. eCollection 2015.

Previous studies have suggested that diabetes significantly impairs the cognitive function. Tangzhining (TZN), as a kind of Traditional Chinese Medicine (TCM), has been widely used to treat diabetes in China. However, the effect of TZN on treatment of diabetes-induced...

Cite
Song X, Wang W, Kang Y, et al. Tangzhining exhibits a protective effect against cognitive dysfunction in diabetic rats. Int J Clin Exp Med. 2015;8(6):9013-21
Song, X., Wang, W., Kang, Y., Zhang, X., Jiang, Y., Yue, Z., & Tang, Z. (2015). Tangzhining exhibits a protective effect against cognitive dysfunction in diabetic rats. International journal of clinical and experimental medicine, 8(6), 9013-21.
Song, Xiaomei, et al. "Tangzhining exhibits a protective effect against cognitive dysfunction in diabetic rats." International journal of clinical and experimental medicine vol. 8,6 (2015): 9013-21.
Song X, Wang W, Kang Y, Zhang X, Jiang Y, Yue Z, Tang Z. Tangzhining exhibits a protective effect against cognitive dysfunction in diabetic rats. Int J Clin Exp Med. 2015 Jun 15;8(6):9013-21. eCollection 2015. PMID: 26309554; PMCID: PMC4538009.
Copy Download .nbib Format: NLM
Nanoscale distribution of Bi atoms in InP.

Scientific reports

Zhang L, Wu M, Chen X, Wu X, Spiecker E, Song Y, Pan W, Li Y, Yue L, Shao J, Wang S.
PMID: 28947809
Sci Rep. 2017 Sep 25;7(1):12278. doi: 10.1038/s41598-017-12075-2.

The nanoscale distribution of Bi in InPBi is determined by atom probe tomography and transmission electron microscopy. The distribution of Bi atoms is not uniform both along the growth direction and within the film plane. A statistically high Bi-content...

Cite
Zhang L, Wu M, Chen X, et al. Nanoscale distribution of Bi atoms in InP. Sci Rep. 2017;7(1):12278doi: 10.1038/s41598-017-12075-2.
Zhang, L., Wu, M., Chen, X., Wu, X., Spiecker, E., Song, Y., Pan, W., Li, Y., Yue, L., Shao, J., & Wang, S. (2017). Nanoscale distribution of Bi atoms in InP. Scientific reports, 7(1), 12278. https://doi.org/10.1038/s41598-017-12075-2
Zhang, Liyao, et al. "Nanoscale distribution of Bi atoms in InP." Scientific reports vol. 7,1 (2017): 12278. doi: https://doi.org/10.1038/s41598-017-12075-2
Zhang L, Wu M, Chen X, Wu X, Spiecker E, Song Y, Pan W, Li Y, Yue L, Shao J, Wang S. Nanoscale distribution of Bi atoms in InP. Sci Rep. 2017 Sep 25;7(1):12278. doi: 10.1038/s41598-017-12075-2. PMID: 28947809; PMCID: PMC5612989.
Copy Download .nbib Format: NLM
Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.

Journal of diabetes investigation

Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y.
PMID: 28921915
J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16.

AIMS/INTRODUCTION: The present phase 3, randomized, double-blind 24-week study with extension to 1 year assessed the efficacy and safety of albiglutide compared with placebo in Japanese patients with type 2 diabetes mellitus inadequately controlled by diet and exercise with...

Cite
Nino A, Okuda I, Wilson TH, et al. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017;doi: 10.1111/jdi.12749.
Nino, A., Okuda, I., Wilson, T. H., Yue, L., Nakajima, H., Tsuboi, M., Carr, M. C., & Seino, Y. (2017). Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Journal of diabetes investigation, . https://doi.org/10.1111/jdi.12749
Nino, Antonio, et al. "Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study." Journal of diabetes investigation vol. (2017). doi: https://doi.org/10.1111/jdi.12749
Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16. PMID: 28921915; PMCID: PMC5934244.
Copy Download .nbib Format: NLM
Time-Course Transcriptome Analysis of Compatible and Incompatible Pollen-Stigma Interactions in .

Frontiers in plant science

Zhang T, Gao C, Yue Y, Liu Z, Ma C, Zhou G, Yang Y, Duan Z, Li B, Wen J, Yi B, Shen J, Tu J, Fu T.
PMID: 28515735
Front Plant Sci. 2017 May 03;8:682. doi: 10.3389/fpls.2017.00682. eCollection 2017.

No abstract available.

Cite
Zhang T, Gao C, Yue Y, et al. Time-Course Transcriptome Analysis of Compatible and Incompatible Pollen-Stigma Interactions in . Front Plant Sci. 2017;8:682doi: 10.3389/fpls.2017.00682.
Zhang, T., Gao, C., Yue, Y., Liu, Z., Ma, C., Zhou, G., Yang, Y., Duan, Z., Li, B., Wen, J., Yi, B., Shen, J., Tu, J., & Fu, T. (2017). Time-Course Transcriptome Analysis of Compatible and Incompatible Pollen-Stigma Interactions in . Frontiers in plant science, 8682. https://doi.org/10.3389/fpls.2017.00682
Zhang, Tong, et al. "Time-Course Transcriptome Analysis of Compatible and Incompatible Pollen-Stigma Interactions in ." Frontiers in plant science vol. 8 (2017): 682. doi: https://doi.org/10.3389/fpls.2017.00682
Zhang T, Gao C, Yue Y, Liu Z, Ma C, Zhou G, Yang Y, Duan Z, Li B, Wen J, Yi B, Shen J, Tu J, Fu T. Time-Course Transcriptome Analysis of Compatible and Incompatible Pollen-Stigma Interactions in . Front Plant Sci. 2017 May 03;8:682. doi: 10.3389/fpls.2017.00682. eCollection 2017. PMID: 28515735; PMCID: PMC5413569.
Copy Download .nbib Format: NLM
Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors.

ACS medicinal chemistry letters

Barsanti PA, Aversa RJ, Jin X, Pan Y, Lu Y, Elling R, Jain R, Knapp M, Lan J, Lin X, Rudewicz P, Sim J, Taricani L, Thomas G, Xiao L, Yue Q.
PMID: 25589927
ACS Med Chem Lett. 2014 Nov 20;6(1):37-41. doi: 10.1021/ml500353p. eCollection 2015 Jan 08.

A saturation strategy focused on improving the selectivity and physicochemical properties of ATR inhibitor HTS hit 1 led to a novel series of highly potent and selective tetrahydropyrazolo[1,5-a]pyrazines. Use of PI3Kα mutants as ATR crystal structure surrogates was instrumental...

Cite
Barsanti PA, Aversa RJ, Jin X, et al. Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS Med Chem Lett. 2014;6(1):37-41doi: 10.1021/ml500353p.
Barsanti, P. A., Aversa, R. J., Jin, X., Pan, Y., Lu, Y., Elling, R., Jain, R., Knapp, M., Lan, J., Lin, X., Rudewicz, P., Sim, J., Taricani, L., Thomas, G., Xiao, L., & Yue, Q. (2015). Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS medicinal chemistry letters, 6(1), 37-41. https://doi.org/10.1021/ml500353p
Barsanti, Paul A, et al. "Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors." ACS medicinal chemistry letters vol. 6,1 (2015): 37-41. doi: https://doi.org/10.1021/ml500353p
Barsanti PA, Aversa RJ, Jin X, Pan Y, Lu Y, Elling R, Jain R, Knapp M, Lan J, Lin X, Rudewicz P, Sim J, Taricani L, Thomas G, Xiao L, Yue Q. Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS Med Chem Lett. 2014 Nov 20;6(1):37-41. doi: 10.1021/ml500353p. eCollection 2015 Jan 08. PMID: 25589927; PMCID: PMC4291715.
Copy Download .nbib Format: NLM
Origin and speciation of .

Plant molecular biology reporter

Li L, Sun Y, Zou J, Yue W, Wang X, Liu J.
PMID: 25999663
Plant Mol Biol Report. 2015;33(3):661-672. doi: 10.1007/s11105-014-0774-5.

Elucidating the evolutionary history of current species diversity, especially trees with large effective population sizes and long generation times, is a complicated exercise confounded by gene flow and incomplete lineage sorting. In the present study, we aim to determine...

Cite
Li L, Sun Y, Zou J, et al. Origin and speciation of . Plant Mol Biol Report. 2015;33(3):661-672doi: 10.1007/s11105-014-0774-5.
Li, L., Sun, Y., Zou, J., Yue, W., Wang, X., & Liu, J. (2015). Origin and speciation of . Plant molecular biology reporter, 33(3), 661-672. https://doi.org/10.1007/s11105-014-0774-5
Li, Lili, et al. "Origin and speciation of ." Plant molecular biology reporter vol. 33,3 (2015): 661-672. doi: https://doi.org/10.1007/s11105-014-0774-5
Li L, Sun Y, Zou J, Yue W, Wang X, Liu J. Origin and speciation of . Plant Mol Biol Report. 2015;33(3):661-672. doi: 10.1007/s11105-014-0774-5. PMID: 25999663; PMCID: PMC4432025.
Copy Download .nbib Format: NLM
Probing charge transfer in a novel class of luminescent perovskite-based heterostructures composed of quantum dots bound to RE-activated CaTiO3 phosphors.

Nanoscale

Lewis CS, Liu H, Han J, Wang L, Yue S, Brennan NA, Wong SS.
PMID: 26725486
Nanoscale. 2016 Jan 28;8(4):2129-42. doi: 10.1039/c5nr06697b.

We report on the synthesis and structural characterization of novel semiconducting heterostructures composed of cadmium selenide (CdSe) quantum dots (QDs) attached onto the surfaces of novel high-surface area, porous rare-earth-ion doped alkaline earth titanate micron-scale spherical motifs, i.e. both...

Cite
Lewis CS, Liu H, Han J, et al. Probing charge transfer in a novel class of luminescent perovskite-based heterostructures composed of quantum dots bound to RE-activated CaTiO3 phosphors. Nanoscale. 2016;8(4):2129-42doi: 10.1039/c5nr06697b.
Lewis, C. S., Liu, H., Han, J., Wang, L., Yue, S., Brennan, N. A., & Wong, S. S. (2016). Probing charge transfer in a novel class of luminescent perovskite-based heterostructures composed of quantum dots bound to RE-activated CaTiO3 phosphors. Nanoscale, 8(4), 2129-42. https://doi.org/10.1039/c5nr06697b
Lewis, Crystal S, et al. "Probing charge transfer in a novel class of luminescent perovskite-based heterostructures composed of quantum dots bound to RE-activated CaTiO3 phosphors." Nanoscale vol. 8,4 (2016): 2129-42. doi: https://doi.org/10.1039/c5nr06697b
Lewis CS, Liu H, Han J, Wang L, Yue S, Brennan NA, Wong SS. Probing charge transfer in a novel class of luminescent perovskite-based heterostructures composed of quantum dots bound to RE-activated CaTiO3 phosphors. Nanoscale. 2016 Jan 28;8(4):2129-42. doi: 10.1039/c5nr06697b. PMID: 26725486.
Copy Download .nbib Format: NLM
Correction: Detection of Alicyclobacillus spp. in Fruit Juice by Combination of Immunomagnetic Separation and a SYBR Green I Real-Time PCR Assay.

PloS one

Cai R, Wang Z, Yuan Y, Liu B, Wang L, Yue T.
PMID: 26726813
PLoS One. 2016 Jan 04;11(1):e0146556. doi: 10.1371/journal.pone.0146556. eCollection 2016.

No abstract available.

Cite
Cai R, Wang Z, Yuan Y, et al. Correction: Detection of Alicyclobacillus spp. in Fruit Juice by Combination of Immunomagnetic Separation and a SYBR Green I Real-Time PCR Assay. PLoS One. 2016;11(1):e0146556doi: 10.1371/journal.pone.0146556.
Cai, R., Wang, Z., Yuan, Y., Liu, B., Wang, L., & Yue, T. (2016). Correction: Detection of Alicyclobacillus spp. in Fruit Juice by Combination of Immunomagnetic Separation and a SYBR Green I Real-Time PCR Assay. PloS one, 11(1), e0146556. https://doi.org/10.1371/journal.pone.0146556
Cai, Rui, et al. "Correction: Detection of Alicyclobacillus spp. in Fruit Juice by Combination of Immunomagnetic Separation and a SYBR Green I Real-Time PCR Assay." PloS one vol. 11,1 (2016): e0146556. doi: https://doi.org/10.1371/journal.pone.0146556
Cai R, Wang Z, Yuan Y, Liu B, Wang L, Yue T. Correction: Detection of Alicyclobacillus spp. in Fruit Juice by Combination of Immunomagnetic Separation and a SYBR Green I Real-Time PCR Assay. PLoS One. 2016 Jan 04;11(1):e0146556. doi: 10.1371/journal.pone.0146556. eCollection 2016. PMID: 26726813; PMCID: PMC4699685.
Copy Download .nbib Format: NLM
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

Open forum infectious diseases

Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R.
PMID: 25734170
Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec.

BACKGROUND: Avian influenza A/H5N1 has threatened human health for nearly 2 decades. Avian influenza A vaccine without adjuvant is poorly immunogenic. A flexible rapid tactic for mass vaccination will be needed if a pandemic occurs.METHODS: A multicenter, randomized, blinded...

Cite
Mulligan MJ, Bernstein DI, Frey S, et al. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014;1(3):ofu102doi: 10.1093/ofid/ofu102.
Mulligan, M. J., Bernstein, D. I., Frey, S., Winokur, P., Rouphael, N., Dickey, M., Edupuganti, S., Spearman, P., Anderson, E., Graham, I., Noah, D. L., Mangal, B., Kim, S., Hill, H., Whitaker, J., Emery, W., Beck, A., Stephens, K., Hartwell, B., Ogilvie, M., Rimann, N., Osinski, E., Destefano, E., Gajadhar, T., Strudwick, A., Pierce, K., Lai, L., Yue, L., Wang, D., Ying, C., Cline, A., Foltz, T., Wagner, N., Dull, G., Pacatte, T., Taggart, B., Johnson, V., Haller, L., Looney, C., Li, S., May, M., Myers, B., May, R., Parker, L., Cochran, N., Bowen, D., Bell, M., Scoggins, J., Burns, A., Stablein, C., Wolff, M., Jolles, B., Leung, B., Lambert, L., Shorer, S., Buchanan, W., Murray, S., Chang, S., & Gorman, R. (2014). Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open forum infectious diseases, 1(3), ofu102. https://doi.org/10.1093/ofid/ofu102
Mulligan, Mark J, et al. "Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial." Open forum infectious diseases vol. 1,3 (2014): ofu102. doi: https://doi.org/10.1093/ofid/ofu102
Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec. PMID: 25734170; PMCID: PMC4324215.
Copy Download .nbib Format: NLM
A pharmacokinetic study of Isatin in Beagles' bodies.

Experimental and therapeutic medicine

Ren A, Su B, Ye S, Wei X, Fang Z, Wang Q, Zhang J, Xu W, Yue W, Yin L, Liu Z, Li X, Ding BO.
PMID: 27284305
Exp Ther Med. 2016 Jun;11(6):2225-2228. doi: 10.3892/etm.2016.3232. Epub 2016 Apr 06.

Isatin are marine active drugs that exert anti-cancer effects, have a cancer-prevention function, and possess many pharmacological activities. The study aimed to examine the pharmacokinetics of a single intravenous injection and oral medication of Isatin given to Beagles. Nine...

Cite
Ren A, Su B, Ye S, et al. A pharmacokinetic study of Isatin in Beagles' bodies. Exp Ther Med. 2016;11(6):2225-2228doi: 10.3892/etm.2016.3232.
Ren, A., Su, B., Ye, S., Wei, X., Fang, Z., Wang, Q., Zhang, J., Xu, W., Yue, W., Yin, L., Liu, Z., Li, X., & Ding, B. O. (2016). A pharmacokinetic study of Isatin in Beagles' bodies. Experimental and therapeutic medicine, 11(6), 2225-2228. https://doi.org/10.3892/etm.2016.3232
Ren, Ailing, et al. "A pharmacokinetic study of Isatin in Beagles' bodies." Experimental and therapeutic medicine vol. 11,6 (2016): 2225-2228. doi: https://doi.org/10.3892/etm.2016.3232
Ren A, Su B, Ye S, Wei X, Fang Z, Wang Q, Zhang J, Xu W, Yue W, Yin L, Liu Z, Li X, Ding BO. A pharmacokinetic study of Isatin in Beagles' bodies. Exp Ther Med. 2016 Jun;11(6):2225-2228. doi: 10.3892/etm.2016.3232. Epub 2016 Apr 06. PMID: 27284305; PMCID: PMC4887780.
Copy Download .nbib Format: NLM
A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo.

American journal of cancer research

Zhang X, Ma Y, Wei H, Li B, Xiao F, Yang J, Yue Q, Yang A, Hao X.
PMID: 27293998
Am J Cancer Res. 2016 May 01;6(5):1053-65. eCollection 2016.

Polypeptide APP8 is a prostate-specific antigen (PSA)-activated prodrug that was designed to synergize the effects of the Bcl-2 homology domain 3 (BH3) peptide, K237 and the DG2 peptide. The aim of this study is to evaluate its biodistribution and...

Cite
Zhang X, Ma Y, Wei H, et al. A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo. Am J Cancer Res. 2016;6(5):1053-65
Zhang, X., Ma, Y., Wei, H., Li, B., Xiao, F., Yang, J., Yue, Q., Yang, A., & Hao, X. (2016). A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo. American journal of cancer research, 6(5), 1053-65.
Zhang, Xiang, et al. "A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo." American journal of cancer research vol. 6,5 (2016): 1053-65.
Zhang X, Ma Y, Wei H, Li B, Xiao F, Yang J, Yue Q, Yang A, Hao X. A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo. Am J Cancer Res. 2016 May 01;6(5):1053-65. eCollection 2016. PMID: 27293998; PMCID: PMC4889719.
Copy Download .nbib Format: NLM
A thieno[3,2-b][1]benzothiophene isoindigo building block for additive- and annealing-free high-performance polymer solar cells.

Advanced materials (Deerfield Beach, Fla.)

Yue W, Ashraf RS, Nielsen CB, Collado-Fregoso E, Niazi MR, Yousaf SA, Kirkus M, Chen HY, Amassian A, Durrant JR, McCulloch I.
PMID: 26175063
Adv Mater. 2015 Aug 26;27(32):4702-7. doi: 10.1002/adma.201501841. Epub 2015 Jul 14.

A novel photoactive polymer with two different molecular weights is reported, based on a new building block: thieno[3,2-b][1]benzothiophene isoindigo. Due to the improved crystallinity, optimal blend morphology, and higher charge mobility, solar-cell devices of the high-molecular-weight polymer exhibit a...

Cite
Yue W, Ashraf RS, Nielsen CB, et al. A thieno[3,2-b][1]benzothiophene isoindigo building block for additive- and annealing-free high-performance polymer solar cells. Adv Mater. 2015;27(32):4702-7doi: 10.1002/adma.201501841.
Yue, W., Ashraf, R. S., Nielsen, C. B., Collado-Fregoso, E., Niazi, M. R., Yousaf, S. A., Kirkus, M., Chen, H. Y., Amassian, A., Durrant, J. R., & McCulloch, I. (2015). A thieno[3,2-b][1]benzothiophene isoindigo building block for additive- and annealing-free high-performance polymer solar cells. Advanced materials (Deerfield Beach, Fla.), 27(32), 4702-7. https://doi.org/10.1002/adma.201501841
Yue, Wan, et al. "A thieno[3,2-b][1]benzothiophene isoindigo building block for additive- and annealing-free high-performance polymer solar cells." Advanced materials (Deerfield Beach, Fla.) vol. 27,32 (2015): 4702-7. doi: https://doi.org/10.1002/adma.201501841
Yue W, Ashraf RS, Nielsen CB, Collado-Fregoso E, Niazi MR, Yousaf SA, Kirkus M, Chen HY, Amassian A, Durrant JR, McCulloch I. A thieno[3,2-b][1]benzothiophene isoindigo building block for additive- and annealing-free high-performance polymer solar cells. Adv Mater. 2015 Aug 26;27(32):4702-7. doi: 10.1002/adma.201501841. Epub 2015 Jul 14. PMID: 26175063.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 6075 entries